US20090030512A1
Active / In Force
US
⏱️ 0.8 years remaining
Circulatory valve, system and method
Assignee: Boston Scientific Scimed Inc
•
Filing: 2007-07-26
•
Granted: —
•
Expires: 2027-07-26
Abstract
Abstract Apparatuses, systems, and methods for use in a vascular system. The apparatus include a circulatory valve having a valve frame in which frame members define frame cells. Frame cells include joints in opposing relationship, where the joints transition from a first stable equilibrium state through an unstable equilibrium state to a second stable equilibrium state as the joints are drawn towards each other.
Inventors
- 👤 Joseph M. Thielen
- 👤 Jason P. Hill
- 👤 Mark L. Jenson
- 👤 William J. Drasler
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 22:07
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2427; A61F2/243; A61F2/2433; A61F2/2412; A61F2/2418; A61F2/2436; A61F2/2475; A61F2/82; A61F2/95; A61F2/2439; A61F2/962; A61F2/966; A61F2002/9665; A61F2210/00; A61F2210/0076; A61F2230/00; A61F2230/0002; A61F2230/0004; A61F2230/0013
Claims Analysis
Total Claims: 24
Claim 1
Independent Claim
58 words
1 . A circulatory valve, comprising: a valve frame having frame members defining frame cells with joints in opposing relationship, where the joints transition from a first stable equilibrium state through an unstable equilibrium state to a second stable equilibrium state as the joints are drawn towards each other; and a valve leaflet coupled to the valve frame.
Claim 2
Dependent Claim
58 words
1 . A circulatory valve, comprising: a valve frame having frame members defining frame cells with joints in opposing relationship, where the joints transition from a first stable equilibrium state through an unstable equilibrium state to a second stable equilibrium state as the joints are drawn towards each other; and a valve leaflet coupled to the valve frame.
Claim 3
Dependent Claim
45 words
2 . The circulatory valve of claim 1 , where the first stable equilibrium state and the second stable equilibrium state are positions of relative potential energy minimums to which the joints of the frame cells return when the unstable equilibrium state is not achieved.
Claim 4
Dependent Claim
29 words
3 . The circulatory valve of claim 1 , where the frame members includes a compliant segment that assists in holding the joints in the second stable equilibrium state.
Claim 5
Dependent Claim
31 words
4 . The circulatory valve of claim 1 , where the frame cells are positioned at at least one of a distal end and a proximal end of the valve frame.
Claim 6
Dependent Claim
37 words
5 . The circulatory valve of claim 1 , where the frame members define a predefined frame design that extends between the frame cells, where the predefined frame design and the frame cells have a different configuration.
Claim 7
Dependent Claim
32 words
6 . The circulatory valve of claim 1 , where the frame cells include a lock mechanism that engages to prevent the frame cell from transitioning from the second stable equilibrium state.
Claim 8
Dependent Claim
55 words
7 . The circulatory valve of claim 6 , where the lock mechanism includes a first engagement member that extends from a first joint to engage a second engagement member that extends from a second joint of the frame cell as the joints transition from the unstable equilibrium state to the second stable equilibrium state.
Claim 9
Dependent Claim
26 words
8 . The circulatory valve of claim 1 , where the first stable equilibrium state is eighty (80) to ninety-five (95) percent of a deployed state.
Claim 10
Dependent Claim
60 words
9 . A method for staged deployment of a circulatory valve, comprising: radially expanding a valve frame of the circulatory valve from an undeployed state to a first stable equilibrium state; and transitioning joints of the valve frame from the first stable equilibrium state through an unstable equilibrium state to a second stable equilibrium state to deploy the circulatory valve.
Claim 11
Dependent Claim
60 words
9 . A method for staged deployment of a circulatory valve, comprising: radially expanding a valve frame of the circulatory valve from an undeployed state to a first stable equilibrium state; and transitioning joints of the valve frame from the first stable equilibrium state through an unstable equilibrium state to a second stable equilibrium state to deploy the circulatory valve.
Claim 12
Dependent Claim
27 words
10 . The method of claim 9 , where radially expanding the valve frame from the undeployed state includes releasing the circulatory valve from the undeployed state.
Claim 13
Dependent Claim
42 words
11 . The method of claim 9 , where transitioning the joints from the first stable equilibrium state through the unstable equilibrium state to the second stable equilibrium state includes drawing the joints in each of a frame cell toward each other.
Claim 14
Dependent Claim
36 words
12 . The method of claim 11 , where stopping the movement of the joints in each frame cell before passing the unstable equilibrium state causes the joints to return toward the first stable equilibrium state.
Claim 15
Dependent Claim
30 words
13 . The method of claim 9 , where transitioning joints of the valve frame include pulling the joints through the unstable equilibrium state to the second stable equilibrium state.
Claim 16
Dependent Claim
23 words
14 . The method of claim 9 , including locking the valve frame in the second stable equilibrium state with a lock mechanism.
Claim 17
Dependent Claim
52 words
15 . The method of claim 9 , including flexing a compliant segment of the valve frame as the joints of the valve frame transition from the first stable equilibrium state through the unstable equilibrium state to the second stable equilibrium state to help hold the circulatory valve in the deployed state.
Claim 18
Dependent Claim
39 words
16 . The method of claim 9 , where transitioning the joints includes elastically deforming the joints from the first stable equilibrium state through the unstable equilibrium state to the second stable equilibrium state to deploy the circulatory valve.
Claim 19
Dependent Claim
38 words
17 . The method of claim 9 , where radially expanding the valve frame includes expanding the valve frame to eighty (80) to ninety-five (95) percent of the second stable equilibrium state for the first stable equilibrium state.
Claim 20
Dependent Claim
124 words
18 . A system, comprising: an elongate delivery catheter; a retractable sheath positioned around at least a portion of the elongate delivery catheter, where the retractable sheath moves longitudinally relative the elongate delivery catheter; a circulatory valve positioned between the elongate delivery catheter and the retractable sheath, where the circulatory valve includes a valve frame having frame members defining frame cells with joints in opposing relationship, and a valve leaflet coupled to the valve frame; and deployment threads that extend longitudinally between the elongate delivery catheter and the retractable sheath to the joints of the frame cells, where force applied through the deployment threads transitions the joints from a first stable equilibrium state through an unstable equilibrium state to a second stable equilibrium state.
Claim 21
Dependent Claim
124 words
18 . A system, comprising: an elongate delivery catheter; a retractable sheath positioned around at least a portion of the elongate delivery catheter, where the retractable sheath moves longitudinally relative the elongate delivery catheter; a circulatory valve positioned between the elongate delivery catheter and the retractable sheath, where the circulatory valve includes a valve frame having frame members defining frame cells with joints in opposing relationship, and a valve leaflet coupled to the valve frame; and deployment threads that extend longitudinally between the elongate delivery catheter and the retractable sheath to the joints of the frame cells, where force applied through the deployment threads transitions the joints from a first stable equilibrium state through an unstable equilibrium state to a second stable equilibrium state.
Claim 22
Dependent Claim
36 words
19 . The system of claim 18 , where the retractable sheath moves longitudinally relative the elongate delivery catheter to allow the circulatory valve to move from an undeployed state to the first stable equilibrium state.
Claim 23
Dependent Claim
27 words
20 . The system of claim 19 , where the first stable equilibrium state is eighty (80) to ninety-five (95) percent of the second stable equilibrium state.
Claim 24
Dependent Claim
66 words
21 . The system of claim 18 , including a push tube that extends longitudinally between the elongate delivery catheter and the retractable sheath to abut at least one of the joints, and where the deployment threads extend through the push tube to the joints of the frame cell to allow force to be applied to the joints between the deployment threads and the push tube.
References Cited (Backward Citations)
US4994077A
Cited
US5713953A
Cited
US5480423A
Cited
US6673109B2
Cited
US20040030405A1
Cited
US6010530A
Cited
US5716370A
Cited
US20060041305A1
Cited
US20040015230A1
Cited
US20060009842A1
Cited
US6837902B2
Cited
US20050004583A1
Cited
US20040002719A1
Cited
US5855600A
Cited
US6508833B2
Cited
US6695866B1
Cited
US6692512B2
Cited
US20060013805A1
Cited
US6336937B1
Cited
US6846324B2
Cited
US20050010285A1
Cited
US20050021056A1
Cited
US20020013571A1
Cited
US20040030382A1
Cited
US20040039442A1
Cited
US20060020275A1
Cited
US20050033446A1
Cited
US20040003819A1
Cited
US20050043792A1
Cited
US20040039443A1
Cited
US20020026216A1
Cited
US6840957B2
Cited
US6685739B2
Cited
US20060000715A1
Cited
US20050015112A1
Cited
US6682559B2
Cited
US6989028B2
Cited
US20040024447A1
Cited
US6840246B2
Cited
US6676698B2
Cited
US6695878B2
Cited
US20040030321A1
Cited
US6846325B2
Cited
US20050010287A1
Cited
US20040015233A1
Cited
US20060025856A1
Cited
US6503272B2
Cited
US20040019378A1
Cited
US6682558B2
Cited
US20050033419A1
Cited
US20050038507A1
Cited
US6676702B2
Cited
US20050027353A1
Cited
US20050027351A1
Cited
US20040034380A1
Cited
US20050043790A1
Cited
US20050033398A1
Cited
US20040039436A1
Cited
US20060020336A1
Cited
US20040010305A1
Cited
US20040024451A1
Cited
US20060041306A1
Cited
US20040019377A1
Cited
US20060030882A1
Cited
US20050021136A1
Cited
US20060030866A1
Cited
US20040019374A1
Cited
US20060025787A1
Cited
US20060025750A1
Cited
US6986775B2
Cited
US6858039B2
Cited
US20040015232A1
Cited
US20040030381A1
Cited
US20040024452A1
Cited
US20040034411A1
Cited
US20060015136A1
Cited
US20060030885A1
Cited
US20060036317A1
Cited
US20050038506A1
Cited
US20060020335A1
Cited
US6997950B2
Cited
US6989027B2
Cited
US20060009841A1
Cited
US20050004667A1
Cited
US20050027261A1
Cited
US20050027348A1
Cited
US20060025784A1
Cited
US20060013855A1
Cited
US20060025857A1
Cited
US20060025854A1
Cited
US20060025855A1
Cited
US20060020334A1
Cited
US20060020332A1
Cited
US20060020327A1
Cited
US20060004439A1
Cited
US20060004442A1
Cited
US20060030747A1
Cited
US20060015178A1
Cited
US20060015179A1
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.